e:Med – Module II – Consortium project: HER2Low – Mathematical modeling of the mechanism of action of therapeutic antibodies directed against Human epidermal growth factor receptor 2, Epidermal growth factor receptor and Erb-B2 receptor tyrosine kinase 3 for the personalization of breast cancer therapy

✏️ Listing Description:

📁 Related Knowledgebase Resources

.

📁 Related Innovation Offers

.

📁 Related Funding and Finance Opportunities

.

Access Restricted

This knowledgebase resource is only fully available for users with Personal Access or Professional Access.

Already member? - Login Get instant access (19,99 € / month) See your options Book a Meeting